Skip to main content
. 2021 Jan 11;27(2):101–109. doi: 10.1016/j.eprac.2021.01.001

Table 2.

Comparison of Survivors to Nonsurvivors

Variable Survivors (n = 44) Nonsurvivors (n = 10) P value Univariate OR (± CI) P valuea Multivariate ORs (+CI)b P valuec Rd
Age, mean (SD) 55.05 (18.43) 74.93 (15.36) .003 1.07 (1.02, 1.12) .007 1.06 (1.00,1.12) .06 0.47
0.21 (0.06, 0.73) .014
 Male (%) 31 (70.5) 6 (60.0) .791
 Female (%) 13 (29.5) 4 (40.0)
BMI, mean (SD) 26.36 (4.87) 26.84 (4.61) .821
Medical background
 DM (%) 14 (31.8) 4 (40.0) .901
 HTN (%) 14 (31.8) 7 (70.0) .061 5.0 (1.12, 22.27) .035 3.81 (0.69, 21.2) .12 0.43
0.18 (0.05, 0.6) .005
 CVA (%) 5 (11.4) 3 (30.0) .315
 IHD (%) 2 (4.5) 3 (30.0) .057
 CHF (%) 1 (2.3) 2 (20.0) .15
Charlson index, mean (SD) 2.48 (2.45) 6.10 (2.13) <.001 1.7 (1.22, 2.37) .0017 1.48 (1.03, 2.14) .035 0.49
0.27 (0.07, 0.97) .04
Thyroid hormones
 TSH (mIU/L) 2.65 (2.65) 3.37 (4.78) .52 1.07 (0.87, 1.31) .51
 FT4 (pmol/L) 13.14 (4.11) 13.49 (3.53) .5 1.02 (0.87, 1.21) .8
 FT3 (pmol/L) 4.65 (0.93) 3.45 (0.77) <.001 0.17 (0.05, 0.54) .003
Laboratory results
 Hb (g/dL) 13.18 (2.23) 11.87 (2.27) .076 0.78 (0.58,1.06) .11
 WBC (K/μL) 7.50 (3.34) 14.66 (7.63) .001 1.34 (1.11, 1.63) .0026 1.28 (1.05, 1.56) .013 0.58
0.2 (0.05, 0.72) .015
 Neutrophils (K/μL) 5.59 (2.90) 12.86 (8.21) .001 1.37 (1.12, 1.67) .0024 1.3 (1.05, 1.61) .015 0.58
0.2 (0.05,0.73) .015
 Lymphocytes (K/μ) 1.09 (0.60) 0.84 (0.35) .3 0.39 (0.09, 1.7) .21
 Albumin (g/dL) 3.70 (0.55) 2.79 (0.59) <.001 0.02 (0.00, 0.25) .003 0.01 (0.00, 0.3) .01 0.67
0.15 (0.03, 0.83) .03
 Cr (mg/dL) 0.88 (0.42) 1.40 (0.99) .08 3.28 (1.09, 9.84) .034 1.2 (0.33, 4.33) .78 0.38
0.19 (0.05, 0.67) .01
 LDH (IU/L) 357.79 (182.22) 489.90 (229.62) .06 1.0 (0.00, 1.01) .07
 D-dimer (ng/mL) 4330.38 (12521.36) 11474.00 (19677.18) .07 1.0 (0.99, 1.00) .23
 Ferritin (ng/mL) 617.44 (651.16) 521.40 (571.27) .95 0.99 (0.99, 1.00) .71
 Troponin-I HS (ng/L) 17.26 (17.17) 213.45 (329.72) <.001 1.05 (1.01, 1.10) .02
 CRP (mg/L) 82.16 (88.61) 143.30 (98.06) .053 1.01 (0.99, 1.01) .07
 AST (IU/L) 52.36 (36.11) 84.1 (88.25) .69 1.01 (0.9998, 1.02) .1
 ALT (IU/L) 35.2 (20.93) 53.6 (61.24) .8
ED clinical parameters on presentation, mean (SD)
 Oxygen room air saturation (%) 88.31 (14.40) 85.90 (13.07) .47
 HR (bpm) 90.15 (17.48) 95.50 (26.12) .46
 RR (respirations/min) 23.84 (10.26) 27.33 (8.19) .34
 Temperature (°C) 37.73 (0.80) 37.53 (0.67) .5
 SBP (mm Hg) 134.37 (18.35) 138.70 (24.27) .54 ….
 DBP (mm Hg) 77.74 (10.49) 82.30 (8.90) .22

Abbreviations: ALT = alanine transaminase; AST = aspartate aminotransferase; BMI = body mass index; bpm = beats/min; CHF = congestive heart failure; Cr = creatinine; CRP = c-reactive protein; CVA = cerebrovascular accident; DBP = diastolic blood pressure; DM, Diabetes mellitus; FT3 = free triiodothyronine; FT4 = free thyroxine; Hb = hemoglobin; HR = heart rate; HS = high sensitivity; HTN, Hypertension; IHD = ischemic heart disease; LDH = lactate dehydrogenase; RR = respiratory rate; SBP = systolic blood pressure; TSH = thyroid stimulating hormone; WBC = white blood cell.

a

P value for univariate model.

b

In the Multivariate OR (CI) column, the first OR (CI) is for the covariate and the second is for FT3

c

P values for multivariate model (with FT3). The P value for FT3 is the second one for each model.

d

Nagelkerke R for Multivariate model (with FT3). R2 for a model with FT3 alone is 0.38.